We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTSI icon
4601
UTStarcom
UTSI
$23.3M
$77K ﹤0.01%
12,237
-4,016
-25% -$22.2K
CYAN
4602
DELISTED
Cyanotech Corp
CYAN
$77K ﹤0.01%
+25,490
New +$77.6K
SPI
4603
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$77K ﹤0.01%
11,554
JWEL icon
4604
Jowell Global
JWEL
$4.46M
$76K ﹤0.01%
+734
New +$86.2K
MBAI
4605
Check-Cap
MBAI
$8.27M
$75K ﹤0.01%
2,932
-1,643
-36% -$51.4K
OBSV
4606
DELISTED
ObsEva SA Ordinary Shares
OBSV
$75K ﹤0.01%
24,966
AGIG
4607
Abundia Global Impact Group
AGIG
$41.4M
$74K ﹤0.01%
2,985
+1,903
+176% +$32.6K
KXIN icon
4608
Kaixin Holdings
KXIN
$8.93M
0
PTPI
4609
DELISTED
Petros Pharmaceuticals
PTPI
$74K ﹤0.01%
95
+38
+67% +$30.4K
BRQS
4610
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$74K ﹤0.01%
267
+58
+28% +$11.4K
CCRC
4611
DELISTED
China Customer Relations Centers, Inc
CCRC
$74K ﹤0.01%
11,412
DYNT
4612
DELISTED
Dynatronics Corp
DYNT
$73K ﹤0.01%
12,232
FWDI
4613
Forward Industries Inc
FWDI
$304M
$72K ﹤0.01%
2,433
+551
+29% +$15K
DVD
4614
DELISTED
Dover Motorsports
DVD
$72K ﹤0.01%
32,258
GRI
4615
GRI Bio
GRI
$2.5M
0
PETZ icon
4616
TDH Holdings
PETZ
$12.2M
$71K ﹤0.01%
1,351
+418
+45% +$20.3K
VIRC icon
4617
Virco
VIRC
$94.4M
$71K ﹤0.01%
20,825
JG
4618
Aurora Mobile
JG
$31.5M
$70K ﹤0.01%
1,086
MOHO
4619
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$70K ﹤0.01%
46,854
VSA
4620
VisionSys AI
VSA
$8.16M
$69K ﹤0.01%
10
ONCY
4621
Oncolytics Biotech
ONCY
$89.9M
$67K ﹤0.01%
24,545
CYTO
4622
DELISTED
Altamira Therapeutics Ltd
CYTO
$67K ﹤0.01%
47
-7
-13% -$9.61K
MDNA
4623
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$67K ﹤0.01%
22,436
+2,674
+14% +$9.89K
MAAS
4624
Maase Inc
MAAS
$8.03B
$66K ﹤0.01%
+205
New +$63.9K
NYMX
4625
DELISTED
Nymox Pharmaceutical Corp
NYMX
$65K ﹤0.01%
41,645
-261,410
-86% -$485K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.